Ontology highlight
ABSTRACT: Background
New drugs and regimens with the potential to transform tuberculosis treatment are presently in early stage clinical trials.Objective
The goal of the present study was to infer the required duration of these treatments.Method
A meta-regression model was developed to predict relapse risk using treatment duration and month 2 sputum culture positive rate as predictors, based on published historical data from 24 studies describing 58 regimens in 7793 patients. Regimens in which rifampin was administered for the first 2 months but not subsequently were excluded. The model treated study as a random effect.Results
The model predicted that new regimens of 4 or 5 months duration with rates of culture positivity after 2 months of 1% or 3%, would yield relaps
SUBMITTER: Wallis RS
PROVIDER: S-EPMC3733776 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature